Literature DB >> 33946332

Cranial Mandibular Fibrosis Syndrome in Adult Farmed Rainbow Trout Oncorhynchus mykiss.

Irene Cano1, John Worswick1, Brian Mulhearn1, Matt Green1, Stephen W Feist1, Morag Clinton1,2.   

Abstract

An unusual condition affecting market size rainbow trout was investigated. This condition was prevalent for several years at low levels but affected a large proportion of stock during 2018 and 2019. Chronic fibrosis affecting cranial tissues and the jaw was observed in samples collected in 2018. A larger sampling was then conducted in 2019 to investigate the presence of an infectious agent(s). An extensive inflammatory response in the mandibular region was the main finding, however infectious agents in the lesions were not identified through classical virology and bacteriology analysis. Tetracapsuloides bryosalmonae infection, calcinosis, and a Gram-positive bacterial infection of a single fish cardiac tissue was observed, however, a correlation of these pathologies and the cranial mandibular fibrosis (CMF) syndrome was not established. The gene expression of a panel of 16 immune-related genes was studied. Among these, tgf-b, sIgM, il11, hspa, and the antimicrobial peptides lys and cath1 were up-regulated in jaw sections of CMF-affected fish, showing a strong positive correlation with the severity of the lesions. Idiopathic chronic fibrosis with the activation of the Tfg-B pathway and local hyper-immunoglobulaemia was therefore diagnosed. Initiating factors and causative agent(s) (biotic or abiotic) of CMF remain, at present, unclear.

Entities:  

Keywords:  PKD; TGF-b; Tetracapsuloides bryosalmonae; calcinosis; dermatitis; immunoglobulaemia; lysozyme; mandibular fibrosis; rainbow trout

Year:  2021        PMID: 33946332     DOI: 10.3390/pathogens10050542

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  65 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A salmonid cell line (TO) for production of infectious salmon anaemia virus (ISAV).

Authors:  H I Wergeland; R A Jakobsen
Journal:  Dis Aquat Organ       Date:  2001-04-10       Impact factor: 1.802

3.  Molecular isolation and characterisation of carp transforming growth factor beta 1 from activated leucocytes.

Authors:  Y Zhan; K Jimmy
Journal:  Fish Shellfish Immunol       Date:  2000-05       Impact factor: 4.581

4.  The Trigeminal (V) and Facial (VII) Cranial Nerves: Head and Face Sensation and Movement.

Authors:  Richard D Sanders
Journal:  Psychiatry (Edgmont)       Date:  2010-01

5.  The production of renal calcinosis by magnesium deficiency in rainbow trout (Salmo gairdneri).

Authors:  C B Cowey; D Knox; J W Adron; S George; B Pirie
Journal:  Br J Nutr       Date:  1977-07       Impact factor: 3.718

6.  Acute dermatitis in farmed trout: an emerging disease.

Authors:  E J Peeler; D Ryder; M A Thrush; J Mewett; J Hulland; S W Feist
Journal:  J Fish Dis       Date:  2014-04-10       Impact factor: 2.767

7.  Molecular studies on the seasonal occurrence and development of five myxozoans in farmed Salmo trutta L.

Authors:  A S Holzer; C Sommerville; R Wootten
Journal:  Parasitology       Date:  2005-10-11       Impact factor: 3.234

8.  Brown trout as biomonitor of heavy metal pollution: effect of age on the reliability of the assessment.

Authors:  A R Linde; S Sánchez-Galán; J I Izquierdo; P Arribas; E Marañón; E García-Vázquez
Journal:  Ecotoxicol Environ Saf       Date:  1998 May-Jun       Impact factor: 6.291

9.  Skeletal anomaly assessment in diploid and triploid juvenile Atlantic salmon (Salmo salar L.) and the effect of temperature in freshwater.

Authors:  G Amoroso; M B Adams; T Ventura; C G Carter; J M Cobcroft
Journal:  J Fish Dis       Date:  2016-01-13       Impact factor: 2.767

10.  Antimicrobial peptides from fish.

Authors:  Jorge A Masso-Silva; Gill Diamond
Journal:  Pharmaceuticals (Basel)       Date:  2014-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.